Connect With Europe’s Most Influential Induced Proximity Experts
The induced proximity field is rapidly expanding, with degraders, molecular glues and non-degrading modalities progressing across oncology, immunology and CNS indications. As biopharma seeks to capitalize on newly validated therapeutic opportunities, demand is growing for technologies and services that can accelerate discovery, strengthen translational confidence and support clinical success.
With momentum at an all-time high following the first PROTAC approval, connect with the companies advancing the next generation of induced proximity therapies and position yourself at the centre of a fast-growing market.
What to Expect?
Gain first-hand insight into the scientific challenges, emerging priorities and future direction of the field to identify new commercial opportunities and strengthen your market positioning
Engage directly with senior decision-makers and scientific experts actively seeking solutions spanning screening technologies, discovery platforms, rational design tools, preclinical models and translational strategies
Showcase your expertise to a highly targeted audience and build relationships with the researchers and drug developers shaping the future of induced proximity in Europe
Elevate your brand and share your solutions with the experts driving biopharma’s most exciting therapeutic modality
Key Services & Solutions
Our biopharma and academic audience is working across glues, heterobifunctionals, antibody-based degraders and non-degrading small molecules, and are looking for service and solution providers with capabilities in the below areas but not limited to:
Assay Development
D2B
DMPK Studies
Tox Studies
Library Development
Mass Spectrometry
HTP Screening
Preclinical Models
cryoEM
Crystallisation & Structural Biology
Proteomics
Reagents
Hear What Our Past Sponsors Have to Say
The highlight of the event was the insightful presentations by the speakers and the chance to interact with them, which helped me gain a better understanding of the TPD domain, current market trends, and ongoing innovations
Business Development Manager, Laurus Synthesis
The scientific content was great, and the number of delegates was optimal for networking. As a service provider, relevant decision makers were present. The event was well organised and executed
Director, Business Development, Concept Life Sciences
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Sam Turner
Business Development Manager